Bulk Manufacturer of Controlled Substances Application: Benuvia Therapeutics Inc., 47521 [2021-18234]
Download as PDF
<![CDATA[
47521
Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices
Certain Laparoscopic Surgical
Staplers, Reload Cartridges, and
Components Thereof; Commission
Determination To Review in Part a
Final Initial Determination Finding a
Violation of Section 337; Schedule for
Filing Written Submissions on the
Issues Under Review and on Remedy,
Public Interest, and Bonding
National Cooperative Research and
Production Act of 1993, 15 U.S.C. 4301
et seq. (‘‘the Act’’), Dynamic Spectrum
Alliance, Inc. has filed written
notifications simultaneously with the
Attorney General and the Federal Trade
Commission disclosing changes in its
membership. The notifications were
filed for the purpose of extending the
Act’s provisions limiting the recovery of
antitrust plaintiffs to actual damages
under specified circumstances.
Specifically, Apple, Cupertino, CA, and
Strathmore University, Nairobi, KENYA
have been added as parties to this
venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and Dynamic
Spectrum Alliance, Inc. intends to file
additional written notifications
disclosing all changes in membership.
On September 1, 2020, Dynamic
Spectrum Alliance, Inc. filed its original
notification pursuant to Section 6(a) of
the Act. The Department of Justice
published a notice in the Federal
Register pursuant to Section 6(b) of the
Act on September 18, 2020 (85 FR
58390).
The last notification was filed with
the Department on May 4, 2021. A
notice was published in the Federal
Register pursuant to Section 6(b) of the
Act on May 25, 2021 (86 FR 28150).
U.S. International Trade
Commission.
ACTION: Correction of notice.
Suzanne Morris,
Chief, Premerger and Division Statistics,
Antitrust Division.
information in support of the claim to
Laura Bryant, Gilcrease Museum, 1400
N Gilcrease Museum Road, Tulsa, OK
74127, telephone (918) 596–2747, email
laura-bryant@utulsa.edu, by September
24, 2021. After that date, if no
additional claimants have come
forward, transfer of control of the sacred
objects and/or objects of cultural
patrimony to the Minnesota Chippewa
Tribe, Minnesota (Mille Lacs Band) may
proceed.
The Gilcrease Museum is responsible
for notifying the Minnesota Chippewa
Tribe, Minnesota (Mille Lacs Band) that
this notice has been published.
Dated: August 11, 2021.
Melanie O’Brien,
Manager, National NAGPRA Program.
[FR Doc. 2021–18270 Filed 8–24–21; 8:45 am]
BILLING CODE 4312–52–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 337–TA–1167]
AGENCY:
Correction is made to notice
86 FR 46882, which was published on
August 20, 2021. There is a
typographical error in the investigation
number on the first page caption
section. The correct investigation
number should read: Investigation No.
337–TA–1167.
SUMMARY:
[FR Doc. 2021–18264 Filed 8–24–21; 8:45 am]
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–872]
khammond on DSKJM1Z7X2PROD with NOTICES
Antitrust Division
Notice Pursuant to the National
Cooperative Research and Production
Act of 1993—Dynamic Spectrum
Alliance, Inc.
Notice is hereby given that, on August
10, 2021, pursuant to Section 6(a) of the
VerDate Sep<11>2014
16:54 Aug 24, 2021
Jkt 253001
7360
7370
I
I
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture the above-listed controlled
substances in bulk to produce finished
dosage forms and conduct research to
develop new drug products and for
clinical studies. In reference to drug
codes 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Brian S. Besser,
Acting Assistant Administrator.
PO 00000
Frm 00053
Fmt 4703
DEPARTMENT OF JUSTICE
Sfmt 4703
[Docket No. DEA–864]
Importer of Controlled Substances
Application: Cedarburg
Pharmaceuticals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Benuvia Therapeutics Inc.,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
SUMMARY:
DEPARTMENT OF JUSTICE
Schedule
Drug Enforcement Administration
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
BILLING CODE 7020–02–P
Marihuana .................................
Tetrahydrocannabinols .............
Drug
code
BILLING CODE P
DEPARTMENT OF JUSTICE
AGENCY:
[FR Doc. 2021–18313 Filed 8–24–21; 8:45 am]
Controlled substance
[FR Doc. 2021–18234 Filed 8–24–21; 8:45 am]
Bulk Manufacturer of Controlled
Substances Application: Benuvia
Therapeutics Inc.
By order of the Commission.
Issued: August 20, 2021.
Lisa Barton,
Secretary to the Commission.
or before October 25, 2021. Such
persons may also file a written request
for a hearing on the application on or
before October 25, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 1, 2021, Benuvia
Therapeutics Inc., 2700 Oakmont Drive,
Round Rock, Texas 78665, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
Cedarburg Pharmaceuticals
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
SUMMARY:
E:\FR\FM\25AUN1.SGM
25AUN1
]]>Agencies
[Federal Register Volume 86, Number 162 (Wednesday, August 25, 2021)]
[Notices]
[Page 47521]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18234]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-872]
Bulk Manufacturer of Controlled Substances Application: Benuvia
Therapeutics Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Benuvia Therapeutics Inc., has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 25,
2021. Such persons may also file a written request for a hearing on the
application on or before October 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on July 1, 2021, Benuvia Therapeutics Inc., 2700 Oakmont
Drive, Round Rock, Texas 78665, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the internal use intermediates or for sale to its
customers. The company plans to manufacture the above-listed controlled
substances in bulk to produce finished dosage forms and conduct
research to develop new drug products and for clinical studies. In
reference to drug codes 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetic. No other activities for these drug codes are
authorized for this registration.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-18234 Filed 8-24-21; 8:45 am]
BILLING CODE P
